Fritextsökning
Innehållstyper
-
Hormones make children fat
A new Danish million project will define the connection between hormons and obesity amongst children.
-
New map of eye proteins
A new mapping of proteins in the eye opens the door for new treatments of eye diseases in the future.
-
Så blir bantade Business Sweden
I somras fick en tredjedel av personalen i den svenska organisationen gå. I det nya Business Sweden som börjar ta form är branschområdena ersatta av geografiska...
-
Apoteket gets new vice CEO
The Swedish government company Apoteket has recently appointed a vice CEO.
-
Dry blood DNA storage on a matrix
Qiagen recently presented a method of dry blood sample storage as an alternative to storage in freezers.
-
Life science in Stockholm
Sweden has the fourth-largest biotech market in Europe. More than half of its biotechnology enterprise, some 460 companies, is located in the Stockholm region.
-
Pharma is a safe market
Pharma is the best industry to invest in. That states leaders from risk capital companies, interviewed by the Economist Intelligence Unit.
-
Lundabolag i spetsen för internationellt kinassamarbete
Ett EU-finansierat forskningskonsortium ska bygga upp en plattform för kinasbaserad läkemedelsutveckling.
-
800 miljoner till svensk export
I Sveriges nya exportstrategi läggs fokus bland annat på SME-bolag och tillväxtmarknader.
-
Nu godkänns Hemlibra för hemofilibehandling
Roche får behandling för hemofili A godkänd av EU-kommissionen.
-
Medicon Valley cluster in brief
The Medicon Valley covers the Öresund region (Skåne and Sjaelland).
-
Vitamin D is mental health aid
Vitamin D can help stave off the mental decline that can affect people in old age, a study suggests.
-
Levercancer nästa mål
Immunicum doserar första patienten i ny klinisk fas I/II-studie.
-
Norwegian describes scrapie gene
Intestinal lymphatic tissue is important for the absorption and spread of the scrapie prion, suggests a Norwegian researcher.
-
EUR 2 million for peanut allergies
ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.
-
Lytix calls in cash
Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.
-
New faces in Pronova Biopharma team
The Norwegian company Pronova Biopharma has recently changed the management team structure.
-
Chilifrukter, smärtläkemedel och katalys – Nobelprisen och forskningen bakom
Nobelveckan är i full gång, och på fredag hyllas pristagarna vid en ceremoni i Blå hallen i Stockholms stadshus med kungligheter och lokal publik på plats, och ...
-
Swedish nanotech crosses the Atlantic
Genovis signs distribution agreement Finnzymes in US.
-
Framåt i interferonfri studie
Medivir redovisar positiva interimsdata av en interferonfri behandling med simeprevir och sofosbuvir.
-
New CEO to Promedvi
Sigrun Axelsson has taken on the leadership of the Lund-based medtech company.
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Success fee to Bioinvent and partner
The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.
-
Växande bransch i Danmark – "Ett nytt life science-företag i veckan"
Life science-sektorn i östra Danmark fortsätter att växa, både i antal anställda och antal företag. Ett uppseglande problem är bristen på arbetskraft, enligt en ny rapport.